The undruggable cancer target: KRAS inhibitors move ahead in the clinic
Some of the deadliest cancer mutations occur in a gene called KRAS. Drugs that target this gene to stop cancer cells from growing further are known as KRAS inhibitors, which have been regarded as a step forward in cancer research. These drugs seem to hold …